"Richard M. Schulze Family Foundation Outpatient Center at McKinley Campus accommodates the growing needs of patients at Moffitt Cancer Center by providing various outpatient services, including diagnostics, cancer screenings, outpatient surgery, clinical research, infusions, genetic counseling, and more. It is located less than a mile from Moffitt Cancer Center's main campus and includes a healing garden and art studio that provide therapeutic services for patients and caregivers going through challenging circumstances."

During the past decade, Moffitt Cancer Center - McKinley Campus conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.1% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 1 clinical trials were completed. i.e. 4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Moffitt Cancer Center - McKinley Campus" #1 sponsor was "National Cancer Institute (NCI)" with 26 trials, followed by "SWOG Cancer Research Network" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Moffitt Cancer Center - McKinley Campus" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Moffitt Cancer Center - McKinley Campus" are "Stage IV Lung Cancer AJCC v8" (5 trials), "Clinical Stage IV Cutaneous Melanoma AJCC v8" (4 trials), "Metastatic Melanoma" (4 trials), "Stage IIIB Lung Cancer AJCC v8" (4 trials) and "Stage IVA Lung Cancer AJCC v8" (4 trials). Many other conditions were trialed in "Moffitt Cancer Center - McKinley Campus" in a lesser frequency.

Most popular intervention types in "Moffitt Cancer Center - McKinley Campus" are "Drug" (35 trials), "Biological" (24 trials), "Other" (21 trials), "Procedure" (16 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (12 trials), "Biospecimen Collection" (10 trials), "Carboplatin" (10 trials), "Cisplatin" (10 trials) and "Questionnaire Administration" (10 trials). Other intervention names were less common.

The vast majority of trials in "Moffitt Cancer Center - McKinley Campus" are 47 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Moffitt Cancer Center - McKinley Campus". undefined are not yet recruiting, 20 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Moffitt Cancer Center - McKinley Campus, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Moffitt Cancer Center - McKinley Campus, 9 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".